Vivacitas Oncology Announces Additions to Leadership Team and Board WALNUT CREEK, Calif., Nov. 30, 2021 (GLOBE NEWSWIRE) -- Vivacitas Oncology, Inc. ("Vivacitas" or the "Company") is pleased to announce the addition of Mark Suseck as new Director and Chief Executive...

Vivacitas Oncology, Inc. to Present on AR-67 at the Annual 5th Meridian Clinical Trials Conference WALNUT CREEK, Calif., Nov. 22, 2021 (GLOBE NEWSWIRE) -- Vivacitas Oncology, Inc., a privately-held oncology company focused on tough-to-treat cancers, will present its lead development candidate,...

Vivacitas Oncology, Inc. and Image Analysis Group to Present on AR-67 Clinical Response Evaluation at the Society for Neuro-Oncology Annual Conference WALNUT CREEK, Calif., Nov. 18, 2021 (GLOBE NEWSWIRE) -- Vivacitas Oncology, a privately-held oncology company focused on tough-to-treat cancers, and Image Analysis Group (IAG), a premier...